Top Brand

18%

Salt Composition

Ferric Carboxymaltose 500mg

Our Recommendation

Raricap FCM 500mg Injection 10ml

Vial of 10 ml

10+ trust this

WHO GMP Certified

10+ trust this

WHO GMP Certified

All Our Medicines are

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

Delivery by

More About Raricap FCM 500mg Injection 10ml

Manufacturer Address

8th Floor, Commerce House IV, Prahladnagar, Ahmedabad ‚ 380015 Gujarat, India

Frequently asked questions

Is Raricap FCM 50mg Injection 10ml safe during pregnancy?

Data on Raricap FCM 50mg Injection 10ml use in pregnancy is limited. Inform your doctor if you are pregnant or planning to become pregnant, and consult them if you become pregnant during treatment to determine the best course of action.

How often can Raricap FCM 50mg Injection 10ml be re-injected?

Typically, two doses are administered 7 days apart, with hemoglobin assessed at least 4 weeks after the final injection. If iron deficiency persists, re-administration may be considered based on individual needs.

How should Raricap FCM 50mg Injection 10ml vials be stored before use?

Raricap FCM 50mg Injection 10ml vials should be stored at 20°C to 25°C (68°F to 77°F) and must not be frozen. The temperature should not exceed 15°C to 30°C (59°F to 86°F).

Can Raricap FCM 50mg Injection 10ml cause an increase in blood pressure?

Yes, Raricap FCM 50mg Injection 10ml may temporarily raise blood pressure, causing facial flushing, dizziness, and nausea, usually resolving within 30 minutes.

What should be done if leakage of Raricap FCM 50mg Injection 10ml occurs?

If leakage occurs during administration, stop immediately. Leakage can lead to skin irritation and long-lasting brown discoloration at the site.

What precautions should be taken when administering Raricap FCM 50mg Injection 10ml?

Raricap FCM 50mg Injection 10ml must be given by trained staff capable of managing severe allergic reactions. It can be administered undiluted directly into the vein or via a dialyzer for dialysis patients, or diluted with sodium chloride for infusion. Patients should be monitored for at least 30 minutes post-injection, and it should not be given subcutaneously or intramuscularly.

Content Written By

Syeda Jigni Mehraj

B pharmacy

1 Years of Experience

Content Reviewed By

Dr. Jay Faldu

MBBS

7 Years of Experience

Checkout Editorial Policy

References

Ferric carboxymaltose. Bagshot Park, Surrey: Vifor Pharma UK Limited; 2007 (23 Jan. 2019)

Ferric Carboxymaltose. 2013 (07 Apr. 2019)

Central Drugs Standard Control Organisation (CDSCO) (07 Apr. 2019)

Ferric carboxymaltose injection (25 Jul. 2024)

Disclaimer

PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.